These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17008851)

  • 1. [Management of hyperbilirubinemia in the newborn infant at 38 or more weeks of gestation].
    Colombo M; Sassi G; Contratti M; Corna A; Sicchiero C; Volpini S; Fazi C; Tedoldi S; Bresciani E; Ciceri A
    Minerva Pediatr; 2006 Aug; 58(4):399-400. PubMed ID: 17008851
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications.
    Maisels MJ; Bhutani VK; Bogen D; Newman TB; Stark AR; Watchko JF
    Pediatrics; 2009 Oct; 124(4):1193-8. PubMed ID: 19786452
    [No Abstract]   [Full Text] [Related]  

  • 3. New guideline for management of hyperbilirubinemia in newborns.
    Adv Neonatal Care; 2004 Aug; 4(4):225. PubMed ID: 15593437
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of hyperbilirubinemia: quality of evidence and cost.
    Holtzman NA
    Pediatrics; 2004 Oct; 114(4):1086-8. PubMed ID: 15466110
    [No Abstract]   [Full Text] [Related]  

  • 5. [Uniform intervention criteria for jaundice in hyperbilirubinemia in preterm infants].
    van Imhoff DE; Dijk PH; Hulzebos CV;
    Ned Tijdschr Geneeskd; 2009; 153():A94. PubMed ID: 19785878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a survey on the use of guidelines in neonatology].
    Knaebel S; Skonetzki S; Nelle M; Wetter T; Linderkamp O
    Z Arztl Fortbild Qualitatssich; 2000 Sep; 94(8):683-8. PubMed ID: 11084724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants >or=35 weeks gestation.
    Bhutani VK; Maisels MJ; Stark AR; Buonocore G; ; ;
    Neonatology; 2008; 94(1):63-7. PubMed ID: 18204221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperbilirubinemia and bilirubin toxicity in the late preterm infant.
    Watchko JF
    Clin Perinatol; 2006 Dec; 33(4):839-52; abstract ix. PubMed ID: 17148008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilirubin problem--the debate continues.
    Newman TB; Klebanoff MA; Maisels MJ
    Pediatrics; 1996 Jul; 98(1):165-6. PubMed ID: 8668399
    [No Abstract]   [Full Text] [Related]  

  • 10. Personal reflections on the AAP practice parameter on management of hyperbilirubinemia in the healthy term newborn.
    Robertson WO
    Pediatr Rev; 1998 Mar; 19(3):75-7. PubMed ID: 9509853
    [No Abstract]   [Full Text] [Related]  

  • 11. [Guidelines for prevention, detection and management of hyperbilirubinaemia in newborns of 35 or more weeks of gestation].
    Sánchez-Redondo Sánchez-Gabriel MD; Leante Castellanos JL; Benavente Fernández I; Pérez Muñuzuri A; Rite Gracia S; Ruiz Campillo CW; Sanz López E; Sánchez Luna M;
    An Pediatr (Barc); 2017 Nov; 87(5):294.e1-294.e8. PubMed ID: 28526241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of babies born extremely preterm at less than 26 weeks of gestation: a framework for clinical practice at the time of birth.
    Wilkinson AR; Ahluwalia J; Cole A; Crawford D; Fyle J; Gordon A; Moorcraft J; Pollard T; Roberts T
    Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F2-5. PubMed ID: 18838468
    [No Abstract]   [Full Text] [Related]  

  • 13. [Guideline 'Prevention, diagnosis and treatment of hyperbilirubinemia in the neonate with a gestational age of 35 or more weeks'].
    Dijk PH; de Vries TW; de Beer JJ;
    Ned Tijdschr Geneeskd; 2009; 153():A93. PubMed ID: 19785881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperbilirubinemia.
    Watson RL
    Crit Care Nurs Clin North Am; 2009 Mar; 21(1):97-120, vii. PubMed ID: 19237047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of hyperbilirubinemia of the newborn].
    Takakura I; Murata Y
    Kango Gijutsu; 1985 Sep; 31(12):1657-61. PubMed ID: 3851886
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.
    Kemper AR; Newman TB; Slaughter JL; Maisels MJ; Watchko JF; Downs SM; Grout RW; Bundy DG; Stark AR; Bogen DL; Holmes AV; Feldman-Winter LB; Bhutani VK; Brown SR; Maradiaga Panayotti GM; Okechukwu K; Rappo PD; Russell TL
    Pediatrics; 2022 Sep; 150(3):. PubMed ID: 35927462
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of Hyperbilirubinemia in Newborn Infants 35 or More Weeks of Gestation: American Academy of Pediatrics, 2022.
    Bhardwaj U; Kohli V; Thukral A
    Indian Pediatr; 2023 Jan; 60(1):63-66. PubMed ID: 36639972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks' gestational age.
    Romagnoli C; Barone G; Pratesi S; Raimondi F; Capasso L; Zecca E; Dani C;
    Ital J Pediatr; 2014 Jan; 40(1):11. PubMed ID: 24485088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal bilirubin screening, guidelines, and evidence.
    Newman TB
    Pediatrics; 2009 Oct; 124(4):1199-202. PubMed ID: 19786453
    [No Abstract]   [Full Text] [Related]  

  • 20. Counseling pregnant women who may deliver extremely premature infants: medical care guidelines, family choices, and neonatal outcomes.
    Kaempf JW; Tomlinson MW; Campbell B; Ferguson L; Stewart VT
    Pediatrics; 2009 Jun; 123(6):1509-15. PubMed ID: 19482761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.